Thank you to Dr. Hussein Tawbi @HTawbi_MD for presenting YCC #GrandRounds sharing the latest advancements in #immune #checkpointinhibitors for #melanoma that has metastasized to the brain. Watch his full talk: piped.video/watch?v=cGWSGPob… @SmilowCancer @MDAndersonNews @yalederm @Yale_CIO @yalepathology

Interested in hearing more about recent progress with #checkpointinhibitors in #LungCancer? 🤔 Join us for our Advances in #LungCancer Webinar! 🫁 💻 Featuring presentations & expert discussions on the latest breakthroughs and #clinical developments in #lungcancer, with a focus on #data and updates from recent international meetings, including ELCC, ASCO, WCLC, and ESMO 2025 🔦 🗓️ Monday 1 December 2025 | 12:30 – 14:30 CST / 18:30 – 20:30 GMT / 19:30 – 21:30 CET 🎙️ Chair: @DrSanjayPopat | Moderators: @MarianaBrandao0, Gregory Riely Agenda: 💡Evolving treatment strategies for EGFRm #NSCLC 💡Recent progress with #checkpointinhibitors 💡Latest with TKIs for #HER2m and ROS+ #NSCLC 💡Advances in #SCLC and high-risk #NSCLC treatment REGISTER NOW ✍️ 👉 us06web.zoom.us/webinar/regi…

🧠 Management strategies for autoimmune liver diseases — including #AIH, #PBC & those induced by #CheckpointInhibitors — expertly discussed by Dr. @kwburak. #LiverDisease #Hepatology #GI #MedEd #ACG2025 @AmCollegeGastro

🧬Advance your immune research with high-quality Checkpoint Inhibitors from Creative Peptides. Explore our products for immune regulation and signaling studies. 👉creative-peptides.com/produc… #CreativePeptides #CheckpointInhibitors #PeptideResearch

Turning All Cancers Into Curable Diseases - Dr. Karen Knudsen MBA PhD - CEO, Parker Institute for Cancer Immunotherapy, joins me on Progress, Potential, And Possibilities #ProstateCancer #CARTCellTherapy #CheckpointInhibitors #TumorAntigens #TumorMicroenvironment

Have cancer vaccines finally reached the turning point? @joshuabrodymd (@TischCancer @SinaiImmunol) breaks down what makes today’s vaccines different, and how they might work hand in hand with checkpoint inhibitors: bit.ly/4o5hU3P #CheckpointInhibitors #Immunotherapy

Advances in Vaccines, Checkpoint Blockade, and Chimeric Antigen Receptor−Based Cancer Immunotherapeutics dl.begellhouse.com/journals/… #CancerImmunotherapy #CheckpointInhibitors #CARTTherapy

New research shows usage of #checkpointinhibitors was well tolerated in treatment of peritoneal #mesothelioma, but efficacy varies widely across individual cases. connectionsoncology.bmj.com/…

Combination therapy of an 211At-labeled RGD peptide and immune checkpoint blockade to enhance antitumor efficacy stellanews.life/science_cate… #Astatine211 #TargetedAlphaTherapy #CheckpointInhibitors #CTLA4 #RGDpeptide #CancerImmunotherapy #KanazawaUniversity #PreclinicalResearch #NuclearMedicine #EJNMMI

4/ 🔓 How Immune #CheckpointInhibitors Work Active cancer immunotherapy activates both cell-mediated and humoral immunity. 🛑 Normally, CTLA-4 helps prevent autoimmunity by turning off T cells. But in cancer: ➡️ CTLA-4 inhibitors block this brake ➡️ T cells stay activated ➡️ Immune system keeps attacking cancer cells Controlled autoimmunity, unleashed on the tumor.